Diabetic Polyneuropathy: Clinical Trials

1 trial for Diabetic Polyneuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Diabetic Polyneuropathy: new trials by email Literature Review of Diabetic Polyneuropathy trials Research Report on Diabetic Polyneuropathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)
Tapentadol extended release (ER), Oxycodone controlled release (CR) - Diabetic Neuropathy, Painful, Diabetic Polyneuropathy
Phase 3TerminatedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.472010-01-012014-03-04

Narrower conditions

Diabetic Neuropathies (1)  ·  Pain (1)  ·  Peripheral Nervous System Diseases (1)  ·  Polyneuropathies (1)

Broader conditions

Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)

Countries

United States (1)